2017 Top Story

- Archives -

Whitney and Yuan named Paul Ambrose Scholars by Association for Prevention Teaching and Research

Whitney and Yuan named Paul Ambrose Scholars by Association for Prevention Teaching and Research

UMass Medical School nursing student Kari Whitney, RN, and medical student Yan Emily Yuan have been named 2017 Paul Ambrose Scholars, an honor that provides support for a local preventive care and public health project.

Dean Flotte delivers 221st Annual Oration to Worcester District Medical Society

Dean Flotte delivers 221st Annual Oration to Worcester District Medical Society

Terence R. Flotte, MD, delivered the Worcester District Medical Society’s 221st Annual Oration, “A Glass (more than) Half Full: Top Ten Reasons to Be Optimistic About the Next 220 Years of Medicine in Worcester,” on Wednesday, Feb. 8, at the Beechwood Hotel.

UMMS epigenetics researcher Oliver Rando explores whether offspring inherit drug protection

UMMS epigenetics researcher Oliver Rando explores whether offspring inherit drug protection

In a study published in the online biomedical sciences journal eLife, Oliver J. Rando, MD, PhD, and colleagues demonstrate that mice born of fathers who are habitually exposed to nicotine inherit enhanced chemical tolerance and drug clearance abilities.

UMMS study finds majority of children with irritable bowel syndrome are low on vitamin D

UMMS study finds majority of children with irritable bowel syndrome are low on vitamin D

A study by Benjamin U. Nwosu, MD, found an unexpectedly high incidence of vitamin D deficiency in children and adolescents with irritable bowel syndrome. The new findings point to monitoring and supplementing vitamin D in children with the disorder.

Chancellor Collins in STAT: Trump’s travel ban will impede science, medicine

Chancellor Collins in STAT: Trump’s travel ban will impede science, medicine

President Trump’s executive order on immigration is hurting America’s medical and science communities, jeopardizing the ability of foreign-born scientists, physicians and students to study and work here, according to an editorial by Chancellor Michael F. Collins published in STAT.

UMMS ranks in top 25 percent of medical schools in NIH funding; departments score high against peers

UMMS ranks in top 25 percent of medical schools in NIH funding; departments score high against peers

UMass Medical School ranked 29th out of 139 U.S. medical schools in National Institutes of Health funding, according to the 2016 report from the Blue Ridge Institute for Medical Research. Ten academic departments at UMMS ranked in the top 50 among their peers at other U.S. medical schools.

Jill Zitzewitz is unraveling protein misfolding to understand disease

Jill Zitzewitz is unraveling protein misfolding to understand disease

Jill A. Zitzewitz, PhD, associate professor of biochemistry & molecular pharmacology, is working to decipher the molecular basis of protein misfolding diseases, such as ALS and Alzheimer’s. Hear more about her research and mentoring in this Women in Science video.

Shlomit Schaal develops methods for early detection of diabetic retinopathy

Shlomit Schaal develops methods for early detection of diabetic retinopathy

Shlomit Schaal, MD, PhD, professor and chair ophthalmology, featured in the latest Women in Science video, studies diabetic retinopathy disease. 

U.S. Rep. James McGovern, local health care leaders discuss impact of Affordable Care Act repeal

U.S. Rep. James McGovern, local health care leaders discuss impact of Affordable Care Act repeal

Speaking to a packed room of local health care leaders at UMass Medical School on Wednesday, Jan. 18, U.S. Rep. James McGovern (D-MA 2nd District) encouraged the crowd to join the Massachusetts congressional delegation in pressing Congress to maintain the Affordable Care Act. 

MassBiologics developing promising alternative treatment for diphtheria in wake of global antitoxin shortage

MassBiologics developing promising alternative treatment for diphtheria in wake of global antitoxin shortage

A worsening shortage of the antitoxin used to treat diphtheria, the deaths of two unvaccinated children to the disease in Europe and declining vaccination rates demonstrate the need for a new approach, and MassBiologics of UMass Medical School is developing one, according to a Jan. 13 story in the journal Science.

Showing 1-10 of 17 items
of 2

Stay Connected with UMassMedNow

For the Media
▴ Back To Top
Section Menu To Top